Skip to main content
Contact Us
Subscribe
E-Edition
38°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Roche Builds Case For Evrysdi Benefits In Younger Spinal Muscular Atrophy Patients
September 24, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
Briefs
News
Biotech
From
Benzinga
WHO Backs Regeneron COVID-19 Antibody Cocktail As It Calls For Equal Access
September 24, 2021
Tickers
REGN
RHHBF
RHHBY
RHHVF
Tags
RHHVF
General
COVID/19 Vaccine
From
Benzinga
Here's Why Everyone's Talking About AstraZeneca Right Now
September 21, 2021
Tickers
AZN
DSNKY
RHHBY
Tags
RHHBY
DSNKY
AZN
From
Motley Fool
AstraZeneca's Enhertu Posts Substantial Clinical Benefit Over Roche's Kadcyla In Breast Cancer Trials
September 20, 2021
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
RHHBY
AZN
ESMO21
From
Benzinga
With Prothena Up Over 500% This Year, Is It Too Late to Get in?
September 18, 2021
Tickers
BIIB
BMY
NVO
PRTA
Tags
NVO
Market News
PRTA
From
Motley Fool
Why Adaptimmune Therapeutics Was Sinking This Week
September 17, 2021
Tickers
ADAP
RHHBY
Tags
RHHBY
Market News
ADAP
From
Motley Fool
The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
September 17, 2021
Tickers
ABCL
ABSI
AGEN
ALZN
Tags
Benzinga
PFE
SNOA
From
Benzinga
Biogen Launches High-Dose Spinraza Trial In Evrysdi Treated Patients: What You Need To Know
September 15, 2021
Tickers
BIIB
RHHBF
RHHBY
RHHVF
Tags
Market News
RHHBY
BIIB
From
Benzinga
Novocure To Test Its Tumor Treating Fields With Roche's Tecentriq In Pancreatic Cancer
September 14, 2021
Tickers
NVCR
RHHBF
RHHBY
RHHVF
Tags
Briefs
Biotech
Benzinga
From
Benzinga
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
September 14, 2021
Tickers
ABT
ACAD
ADGI
ALPMY
Tags
NYXH
AMGN
ALPMY
From
Benzinga
These OTCQX & OTCQB Securities Had the Most Trading Activity in August
September 13, 2021
Tickers
BLLYF
ETHE
GBTC
GDLC
Tags
RHHBY
Markets
GDLC
From
Benzinga
The Week Ahead In Biotech (Sept. 12-18): Calliditas FDA Decision, Adcom Review For Pfizer/BioNTech COVID-19 Vaccine, Oncology Conference And IPOs
September 12, 2021
Tickers
ALRN
AZN
BIIB
BNTX
Tags
CHRS
News
HEPA
From
Benzinga
7 Biotech Stocks to Buy That Have Millionaire-Maker Potential
September 10, 2021
Tickers
AVIR
HSTO
MRNA
NRBO
Tags
Market News
MRNA
SENS
From
InvestorPlace
Why MacroGenics Soared Nearly 9% Higher Today
September 09, 2021
Tickers
MGNX
RHHBY
Tags
MGNX
RHHBY
Market News
From
Motley Fool
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
September 09, 2021
Tickers
ABSI
ABT
AZN
BIVI
Tags
CTLT
NUVL
News
From
Benzinga
Roche Beefs Up PCR-Test Portfolio With TIB Molbiol Acquisition
September 09, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
News
Health Care
Diagnostics
From
Benzinga
2 Stocks I Bought Last Week
September 08, 2021
Tickers
AZN
JYNT
NVAX
PIRS
Tags
RHHBY
SHOP
AZN
From
Motley Fool
MacroGenics' Cancer Drug Margenza Flops On Overall Survival Analysis
September 08, 2021
Tickers
MGNX
RHHBF
RHHBY
RHHVF
Tags
RHHBF
General
Small Cap
From
Benzinga
7 Meme Stocks You Should Keep a Close Eye on for Real Potential
September 07, 2021
Tickers
AMZN
FORD
GM
HOOD
Tags
QUAD
GM
FORD
From
InvestorPlace
Why Adaptimmune Therapeutics Stock Is Bolting Higher Today
September 07, 2021
Tickers
ADAP
RHHBY
Tags
ADAP
Market News
RHHBY
From
Motley Fool
Adaptimmune Stock Moves Higher On Cancer Deal With Genentech
September 07, 2021
Tickers
ADAP
RHHBF
RHHBY
RHHVF
Tags
Small Cap
General
RHHVF
From
Benzinga
Roche's Spark Therapeutics, NeuExcell Join Forces To Develop Huntington's Disease Gene Therapy
September 07, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
Benzinga
Biotech
Briefs
From
Benzinga
Is Exelixis Stock a Buy?
September 02, 2021
Tickers
EXEL
RHHBY
Tags
Market News
BAYR/Y
EXEL
From
Motley Fool
COVID 19 Stocks -- Vaccines, Diagnostics, or Treatments?
August 31, 2021
Tickers
ABT
CDNA
GH
GILD
Tags
GILD
Market News
NVAX
From
Motley Fool
Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates
August 31, 2021
Tickers
ABBV
ASND
BGNE
BIIB
Tags
MIRM
Biotech
IMPL
From
Benzinga
See Why AC Immune Stock Is Trading Higher After Data From Alzheimer's Candidate
August 31, 2021
Tickers
ACIU
RHHBF
RHHBY
RHHVF
Tags
Trading Ideas
Health Care
News
From
Benzinga
After Bladder Cancer, Roche Pulls Breast Cancer Indication For Tecentriq In US
August 27, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
General
RHHVF
FDA
From
Benzinga
Which Biotech Stock Will Shock the Market in 2022?
August 27, 2021
Tickers
AXSM
AZN
NDAQ
NVAX
Tags
NVAX
SGEN
Market News
From
Motley Fool
Shape Therapeutics, Roche Form $3B RNA Editing Collaboration
August 24, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
Gene Editing
News
Health Care
From
Benzinga
Why Shares of Global Blood Therapeutics Are Soaring Today
August 23, 2021
Tickers
CRSP
GBT
RHHBY
VRTX
Tags
Market News
VRTX
CRSP
From
Motley Fool
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.